# Therapeutic role of Cousinia thomsonii in ameliorating the oxidative stress and inflammation: A comprehensive in vitro and in vivo investigation

**Authors:** Bilal Ahmad Reshi, Asif Amin, Umer Majeed, Mushtaq Ahmad Mir, Nasreena Bashir, Raies A. Qadri, Showkat Ahmad Ganie, Muhammad Zeeshan Bhatti, Muhammad Zeeshan Bhatti, Muhammad Zeeshan Bhatti, Muhammad Zeeshan Bhatti, Muhammad Zeeshan Bhatti

PMC · DOI: 10.1371/journal.pone.0343450 · 2026-03-06

## TL;DR

This study shows that Cousinia thomsonii extract reduces oxidative stress and inflammation in cells and animal models, suggesting its potential as a therapeutic herb.

## Contribution

The study provides new evidence for the antioxidant and anti-inflammatory effects of Cousinia thomsonii extract in both in vitro and in vivo models.

## Key findings

- Ethyl acetate extract of Cousinia thomsonii showed higher antioxidant activity than methanolic extract.
- The extract reduced H2O2-induced oxidative stress and cell death in HepG2 cells.
- The extract inhibited NO release and inflammation markers in vitro and reduced paw edema in vivo.

## Abstract

The present study evaluated the antioxidant and anti-inflammatory properties of an edible medicinal herb, Cousinia thomsonii (CT), commonly known as Thomson’s thistle. Preliminary investigations such as DPPH assay, lipid peroxidation estimation, reducing power assessment, hydroxyl radical scavenging activity, and plasmid DNA damage assessment revealed that ethyl-acetate extract of the plant exhibited significantly higher antioxidant potential compared to the methanolic extract. We further evaluated the antioxidant potential of ethylacetate extract of Cousinia thomsonii in model cell systems. Using DCFDA staining, our results showed that ethyl acetate extract of this herb alleviated H2O2-induced oxidative stress in HepG2 cells. Further, the extract protected these cells from H2O2-induced cell death as demonstrated by PI/DAPI staining-based cell viability assays. These data were further substantiated by the cleavage status of PARP as evaluated by immunoblotting which pointed at the rescue of HepG2 cells from H2O2 induced cell death. Inhibition of NO release, corroborated by the downregulation of iNOS, also confirmed the effect of the extract in SNP-induced NO stress. Additionally, co-treatment with different concentrations of the extract led to the upregulation of Nrf2, the master regulator of oxidative stress, while dose-dependently suppressing LPS-induced TNF-α, IL-1β, and IL-6 expression in THP-1 cells.The in vivo anti-inflammatory activity of Cousinia thomsonii was further assessed through inhibition of paw edema formation and histopathological analysis of paw tissue. Taken together, these findings demonstrate that the ethyl acetate extract of CT exhibit potent antioxidant and anti-inflammatory effects in both in vitro and in vivo models, supporting its potential therapeutic application.

## Linked entities

- **Genes:** GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], NOS2 (nitric oxide synthase 2) [NCBI Gene 4843], PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142], TNF (tumor necrosis factor) [NCBI Gene 7124], IL1B (interleukin 1 beta) [NCBI Gene 3553], IL6 (interleukin 6) [NCBI Gene 3569]
- **Chemicals:** H2O2 (PubChem CID 784), NO (PubChem CID 24822), DCFDA (PubChem CID 104913), DAPI (PubChem CID 2954)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, COL11A2 (collagen type XI alpha 2 chain) [NCBI Gene 1302] {aka DFNA13, DFNB53, FBCG2, HKE5, OSMEDA, OSMEDB}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, ISYNA1 (inositol-3-phosphate synthase 1) [NCBI Gene 51477] {aka INO1, INOS, IPS, IPS 1, IPS-1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** cervical dislocation (MESH:D002575), carcinogenesis (MESH:D063646), ACADEMIC EDITOR (MESH:D007859), dermatitis (MESH:D003872), obesity (MESH:D009765), ORCID iD (MESH:C535742), asthma (MESH:D001249), edema (MESH:D004487), cancer (MESH:D009369), diabetes (MESH:D003920), pain (MESH:D010146), Inflammatory (MESH:D007249), liver disease (MESH:D008107), neurodegeneration (MESH:D019636), chronic diseases (MESH:D002908), necrosis (MESH:D009336), liver cancer (MESH:D006528), gastrointestinal ulcers (MESH:D014456), cytotoxic (MESH:D064420), cardiovascular diseases (MESH:D002318), infections (MESH:D007239), colorectal cancer (MESH:D015179), rheumatoid arthritis (MESH:D001172), arthritis (MESH:D001168)
- **Chemicals:** Hydroxyl (MESH:D017665), ethanol (MESH:D000431), ascorbic acid (MESH:D001205), SDS (MESH:D012967), artemisinin (MESH:C031327), Catechin (MESH:D002392), TBA (MESH:C029684), Fe++ (MESH:D007501), DCFDA (MESH:C029569), free radical (MESH:D005609), water (MESH:D014867), benzene (MESH:D001554), lycopene (MESH:D000077276), ferric nitrate (MESH:C025302), NaNO2 (MESH:D012977), Lipid peroxide (MESH:D008054), Ferric chloride (MESH:C024555), DPPH (MESH:C004931), beta-sitosterol (MESH:C025473), Quercetin (MESH:D011794), xylazine (MESH:D014991), EDTA (MESH:D004492), ethidium bromide (MESH:D004996), Phytol (MESH:D010836), Carrageenan (MESH:D002351), oxygen (MESH:D010100), deoxyribose (MESH:D003855), phosphate (MESH:D010710), PI (MESH:D010716), thapsigargin (MESH:D019284), withanolides (MESH:D054358), methanol (MESH:D000432), EGCG (MESH:C045651), paraffin (MESH:D010232), ROS (MESH:D017382), DAPI (MESH:C007293), flavonoids (MESH:D005419), parthenolide (MESH:C002669), formalin (MESH:D005557), chlorogenic acid (MESH:D002726), alcohol (MESH:D000438), Sodium Nitroprusside (MESH:D009599), 9-octadecenoic acid (MESH:D019301), PBS (MESH:D007854), eosin (MESH:D004801), alpha-tocopherol (MESH:D024502), Agarose (MESH:D012685), Naringenin (MESH:C005273), sesquiterpenes (MESH:D012717), Lipid (MESH:D008055), LPS (MESH:D008070), steroids (MESH:D013256), MDA (MESH:D008315), acetone (MESH:D000096), carbohydrates (MESH:D002241), lutein (MESH:D014975), triterpenes (MESH:D014315), TCA (MESH:D014238), Indomethacin (MESH:D007213), peroxide (MESH:D010545)
- **Species:** Withania somnifera (ashwagandha, species) [taxon 126910], Cousinia thomsonii (species) [taxon 554249], Brassica juncea (brown mustard, species) [taxon 3707], Camellia sinensis (black tea, species) [taxon 4442], Curcuma longa (turmeric, species) [taxon 136217], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Cohnella sp. T (species) [taxon 365345]
- **Cell lines:** ET-28A — Homo sapiens (Human), Ewing sarcoma, Cancer cell line (CVCL_9682), pGEX-4T2 — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_2501), HEPG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), pET-28A — Oryctolagus cuniculus (Rabbit), Transformed cell line (CVCL_6E94), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965545/full.md

---
Source: https://tomesphere.com/paper/PMC12965545